Digital Pathology MarketAccurate pathology testing is crucial to help doctors make accurate decisions regarding diagnosis and treatment. Clinical pathology involves the laboratory analysis of blood, urine and tissue samples to examine and diagnose disease. The digital pathology market is growing and is expected to continue to grow in the coming years. The use of scanners and image analysis software enable pathologists to be more efficient and provide improved quality care for patients.

A new report published by Markets and Markets finds that this market that was valued at an estimated $250.2 million in 2013 is now expected to grow at a CAGR of 11.8%, to reach an estimated $437 million by 2018. This report studies the market over the forecast period of 2013 to 2018.

The report named “Digital Pathology Market Slide Scanners (Whole Slide Imaging), Analytics (Image Analysis Software), Delivery Modes (Web Based/Cloud Based) & Whole Slide Image Storage – Global Forecasts & Trends to 2018”, divides the overall digital pathology market on the basis of products, applications, and geographies.

The market is categorized into scanners, analytics, storage, and communication based on products, while it is classified into human and animal pathology based on applications. Human pathology is segmented into pharmaceutical and biotechnology companies, hospitals and reference laboratories, and training and education centers, and animal pathology is segmented into pharmaceutical and biotechnology companies, contract research organizations, and academic and government research institutes.

Based on geography, North America is the largest market, followed by Europe and Asia. The Asian market is also expected to grow at the highest rate over the next five years.

The top players in the market include 3DHistech (Hungary), Leica Biosystems (Germany), Ventana Medical Systems (U.S.), Hamamatsu Photonics K.K. (Japan), Mikroscan Technologies (U.S.), Definiens AG (Germany), Visiopharm (Denmark), and Indica Labs (U.S.).

Triangle Biomedical Sciences, Inc. (TBS) is also an established company that develops, manufactures and markets a comprehensive line of innovative instrumentation, apparatus, reagents and consumables for the medical discipline of histology.